Back to search results

TREAT-BE Study for Barrett's Esophagus and Esophageal Cancer

This study, called TREAT-BE, is looking at how well different treatments work for people with Barrett's Esophagus (a condition where the lining of the esophagus changes) and esophageal cancer. It's an observational study, meaning researchers will watch and collect information about patients who receive treatments like endoscopic eradication therapies (EET), which remove abnormal cells, esophagectomy (surgical removal of the esophagus), chemotherapy, or radiation. The study aims to see if EET improves patient outcomes over five years. You might be able to join if you are between 18 and 100 years old and have Barrett's related neoplasia (abnormal cell growth) or esophageal cancer. The study is currently unclear on its recruitment status and plans to enroll 5000 people.

Study design
This is an observational study with a planned enrollment of 5000 participants.
What's involved
You would complete questionnaires about your symptoms and quality of life. Your medical history, endoscopy results, and details of any treatments you receive will be documented.
Compensation
Not stated in the trial record.
Follow-up
Patient outcomes will be measured at 5 years.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT02634645

TREAT-BE Study (Treatment With Resection and Endoscopic Ablation Techniques for Barrett's Esophagus)

Recruiting
Not specifiedAges 18+Observational
University of Colorado, Denver
~5,000 participants
Updated 2025-02-28 on ClinicalTrials.gov
What's tested:Endoscopic eradication therapies (EET)EsophagectomyChemotherapyRadiation

At a glance

Recruiting sites
4 of 4 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Overall improvement of patient outcomes in patients treated with endoscopic eradication therapy (EET).
Measured over 5 years

Conditions

Barrett's Esophagus
Esophageal Cancer

Explore related trials

Barrett EsophagusEsophageal Carcinoma

Where it's being run

4 sites across 4 states
California1
Florida1
Illinois1
Missouri1

Study leadership

  • Sachin Wani, MD · PRINCIPAL_INVESTIGATOR · University of Colorado, Denver

Who to contact

Sachin Wani, MD
[email protected]
720-848-2786
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Patients with Barrett's related neoplasia and dysplasia. Patients with esophageal cancer

Exclusion

Patients with squamous cell carcinoma

What this trial measures

  • Overall improvement of patient outcomes in patients treated with endoscopic eradication therapy (EET).5 years

    A systematic, prospective collection of data from a large cohort of patients with BE and EAC undergoing EET will provide useful data in effort to improve overall patient outcomes.